For U.S. Healthcare Professionals

Proven Clinical Experience

Only ADVATE® has 15+ years of experience in the real world as a latest-generation plasma/albumin-free recombinant factor VIII8

  • Extensively studied with evidence spanning over a decade from 15 prospective studies2-7
  • Most widely used* with more than 33 billion IUs distributed worldwide9
  • Proven clinical performance2-7
  • Third-generation full-length molecule similar to the factor VIII that occurs naturally in the body1,8

*Based on units sold as of February 2019.

ADVATE prophylaxis may help your patients prevent or reduce the frequency of bleeds

Efficacy

ADVATE prophylaxis may help your patients prevent or reduce the frequency of bleeds1

See data
Learn about safety findings from the ADVATE clinical trials

Established Safety Profile

Learn about safety findings from the ADVATE clinical trials.

See the results